Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,766 | 355 | 73.1% |
| Consulting Fee | $2,300 | 1 | 24.9% |
| Education | $152.47 | 3 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31.20 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $3,950 | 87 | $0 (2024) |
| Gilead Sciences, Inc. | $1,680 | 85 | $0 (2024) |
| Janssen Biotech, Inc. | $966.73 | 73 | $0 (2023) |
| Merck Sharp & Dohme LLC | $543.03 | 29 | $0 (2024) |
| Janssen Products, LP | $372.79 | 4 | $0 (2021) |
| ABBVIE INC. | $361.35 | 13 | $0 (2024) |
| Napo Pharmaceuticals Inc | $222.23 | 10 | $0 (2024) |
| Novo Nordisk Inc | $216.22 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $138.25 | 11 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $121.87 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,235 | 62 | ViiV Healthcare Company ($488.64) |
| 2023 | $1,139 | 53 | Gilead Sciences, Inc. ($254.46) |
| 2022 | $829.94 | 37 | Gilead Sciences, Inc. ($230.97) |
| 2021 | $3,308 | 46 | ViiV Healthcare Company ($2,479) |
| 2020 | $301.74 | 12 | Janssen Products, LP ($99.00) |
| 2019 | $939.24 | 60 | Janssen Biotech, Inc. ($365.21) |
| 2018 | $823.96 | 52 | Gilead Sciences, Inc. ($240.83) |
| 2017 | $673.33 | 39 | ViiV Healthcare Company ($246.21) |
All Payment Transactions
361 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.07 | General |
| 12/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: VIROLOGY | ||||||
| 12/02/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: HIV | ||||||
| 11/26/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: HIV | ||||||
| 11/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: HIV | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: HIV | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.10 | General |
| 11/07/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/21/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: VIROLOGY | ||||||
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.01 | General |
| 09/19/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: HIV | ||||||
| 09/12/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: HIV | ||||||
| 09/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Obesity | ||||||
| 09/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $0.55 | General |
| 08/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.20 | General |
| 08/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.36 | General |
| 08/29/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: Infectious Disease | ||||||
| 08/22/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: HIV | ||||||
| 08/15/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $15.86 | General |
| Category: Cranial Orthotic | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.53 | General |
| 08/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: HIV | ||||||
| 08/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.16 | General |
About Dr. Cory Brown, MD
Dr. Cory Brown, MD is a General Practice healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1912167818.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cory Brown, MD has received a total of $9,250 in payments from pharmaceutical and medical device companies, with $1,235 received in 2024. These payments were reported across 361 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,766).
Practice Information
- Specialty General Practice
- Other Specialties Internal Medicine
- Location Chicago, IL
- Active Since 06/13/2008
- Last Updated 09/19/2022
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1912167818
Products in Payments
- RUKOBIA (Drug) $2,350
- SYMTUZA (Drug) $746.55
- DOVATO (Drug) $650.02
- Symtuza (Drug) $437.21
- TRIUMEQ (Drug) $311.01
- APRETUDE (Biological) $305.09
- VRAYLAR (Drug) $292.20
- PIFELTRO (Drug) $288.25
- PREZCOBIX (Drug) $228.74
- Mytesi (Drug) $222.23
- ISENTRESS (Drug) $218.48
- JULUCA (Drug) $174.29
- CABENUVA (Biological) $159.42
- Ozempic (Drug) $142.08
- ENTRESTO (Drug) $121.87
- Heplisav-B (Drug) $102.50
- Trintellix (Drug) $89.87
- EGRIFTA (Drug) $89.06
- TRINTELLIX (Drug) $70.90
- MAVYRET (Drug) $69.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Chicago
Dr. Louis Graham, D.d.s, D.D.S
General Practice — Payments: $1.0M
Dr. Alan Boghosian, Dds, DDS
General Practice — Payments: $398,247
Dr. Matthew Hallas, Dmd, DMD
General Practice — Payments: $256,018
Louis Kaufman, Dds, DDS
General Practice — Payments: $123,293
Dr. Michael Nick, Dmd, DMD
General Practice — Payments: $104,336
Bow Chung, M.d, M.D
General Practice — Payments: $58,261